Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-COP vs R-COPY in Frail Elderly DLBCL
NCT00911183Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Dec 2008
- Primary completion
- Dec 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in diffuse large B-cell lymphoma (DLBCL), sponsored by Institut Bergonié. Started Dec 2008; status: completed.
02
Drugs
doxorubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00911183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911183.